For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms
...ipolar Depression: Despite Negative Results, Physicians Still Hopeful About aripiprazole
also finds that an oral therapy that carries a lower risk of weight gain t...ipolar Depression: Despite Negative Results, Physicians Still Hopeful About aripiprazole
is a DecisionBase 2009 report. DecisionBase 2009 is a decision-support too...
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
...for use in pediatric patients with depression (see Boxed WARNING).
Contraindication : Patients should not use ABILIFY if they are allergic to aripiprazole
or any of the ingredients in ABILIFY. Allergic reactions have ranged from rash, hives and itching to anaphylaxis, which may include difficulty breath...
Most Newer Antipsychotics No Better Than Older Ones, Just Different
...all to medium effect sizes."
But, other second generation drugs, such as aripiprazole
(Abilify), quetiapine (Seroquel), sertindole (Serdolect), ziprasidone (Geod...fective than first-generation drugs, the researchers reported.
And, only aripiprazole
and ziprasidone among the second-generation drugs did not induce more weigh...
Comparison of antipsychotic treatments in adolescents with schizophrenia
...e the treatment of children and adolescents with schizophrenia. Although the U.S. Food and Drug Administration (FDA) has recently approved the use of aripiprazole
and risperidone for adolescents with schizophrenia, few controlled data are available to help guide clinicians regarding the management of children an...
Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
...r an antipsychotic medication, although young patients were more likely to be prescribed one of the newer, atypical antipsychotic medications, such as aripiprazole
(Abilify) or olanzapine (Zyprexa), than other types of antipsychotics. This finding suggests that doctors may be basing their treatment choices for bi...
US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors
...pical antipsychotics are second-generation medicines designed to cause fewer neurological complications than conventional antipsychotics. They include aripiprazole
(sold as Abilify), olanzapine (Zyprexa), quetiapine (Seroquel), risperidone (Risperdal), and ziprasidone (Geodon). Each is approved by the Food and Dr...
No Evidence to Support Many Off-label Uses of Atypical Antipsychotics
...ons than conventional antipsychotics. They include aripiprazole
(sold as Abilify), olanzapine (Zyprexa), quetiapin...nalysis showed a small benefit for risperidone and aripiprazole
in the treatment of agitation and psychosis. Anoth...atients with schizotypal personality disorder, and aripiprazole
may help patients with borderline personality diso...
Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
...which broadly covers zonisamide in combination
with various marketed atypical antipsychotics including olanzapine,
clozapine, risperidone, quetiapine, aripiprazole
and ziprasidone through
2025. We believe that these patents complement each other and provide a
strong patent portfolio for OREX-003. Orexigen has lic...
OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
If issued, this patent will also cover zonisamide in combination with
other atypical antipsychotics, including clozapine, risperidone,
and ziprasidone. Zonisamide is also a component of
the Company's obesity treatment candidate Empatic(TM), which is in the
later stages of Phase II cli...
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
...ty survey replication (NCS-R). JAMA. June 18 2003;289(23):3095-3105. (3) Berman RM, Marcus RN, Swanink R, et al. The Efficacy and Safety of aripiprazole
as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. J Clin Psychiatry. 20...